If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: virginiacancerspecialists.com/insurance/.

ASCO Adapts CCO Guideline on Selection of Optimal Adjuvant Therapies for HER2-Negative and HER2-Posi

Virginia Cancer Specialists Practice Blog

September 12, 2016
Virginia Cancer Specialists » VCS Practice News » Blog Post » ASCO Adapts CCO Guideline on Selection of Optimal Adjuvant Therapies for HER2-Negative and HER2-Posi

Virginia Cancer Specialist’s Dr. Denduluri, is the co-chiar of an expert ASCO panel.

Recent Posts

Virginia Cancer Specialists Earns Re-Certification from QOPI® for Excellence in Oncology Care
Virginia Cancer Specialists Earns Re-Certification from QOPI® for Excellence in Oncology Care
November 5, 2025
Read More
29 Physicians from Virginia Cancer Specialists Named to Washingtonian Magazine’s Top Doctors List 2025
29 Physicians from Virginia Cancer Specialists Named to Washingtonian Magazine’s Top Doctors List 2025
October 27, 2025
Read More
Dr. Danijela Jelovac and Dr. Lindy Rosal Spotlighted in Washingtonian for Advancing Breast Cancer Treatment
Dr. Danijela Jelovac and Dr. Lindy Rosal Spotlighted in Washingtonian for Advancing Breast Cancer Treatment
October 7, 2025
Read More
Woodbridge Parking - Ongoing Maintenance from October 6th through October 19th, 2025.
Woodbridge Parking - Ongoing Maintenance from October 6th through October 19th, 2025.
October 6, 2025
Read More
Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer
Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer
September 24, 2025
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top